On March 11, 2020, Arkansas announced its first case of COVID-19 in Pine Bluff. What followed was weeks of uncertainty and months of business-as-anything-but-normal as the state and country sought to minimize new cases and economic damage in a pandemic without modern precedent. As COVID-19 ambiguity turns into normalcy, employers face a host of questions about topics such as vaccination and vaccine financing, future costs, long-term health and wellness of affected employees, return-to-work best practices and more. We’d like to help answer some of those questions based on what we’re seeing as a health insurer and discuss more of what we know about COVID-19 and your business.
Date: Tuesday, February 9, 2021
Time: 1 to 2:30 p.m.
We’re bringing together a diverse cross-section of experts from all areas of our company, including Mark Jansen, M.D., vice president and chief medical officer, Joanna Thomas, M.D., vice president of clinical strategy and population health, Victor Davis, vice president of actuarial services and chief actuary, Marcus James, senior vice president of claims and membership, Aaron Novotny, Ph.D., health economist and Odell Nickelberry, vice president of human resources. Our expert panel will share a wide range of insights with Arkansas employers and business decision-makers that oversee their company’s health plan.
The specter of COVID-19 has cast a long shadow and created an abundance of market confusion, especially when it’s your job to manage your company’s health plan and the health of dozens or even hundreds of employees. We want to lend some clarity. Join our webinar, COVID-19: What can your company expect, Tuesday, February 9 at 1 p.m.